Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(33.3%)
Early Phase 1
1(33.3%)
Phase 1
1(33.3%)
3Total
N/A(1)
Early Phase 1(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06020586Not ApplicableUnknown

Study To Evaluate The Efficacy And Safety Profile of ECOHAIR in Chemo-induced Alopecia.

Role: lead

NCT03338777Early Phase 1Terminated

Suicide Plus Immune Gene Therapy for Advanced Melanoma

Role: collaborator

NCT02844387Phase 1Completed

Supplementation of L-arginine in Patients With Non-resectable Brain Metastases

Role: lead

All 3 trials loaded